Tuberculosis researchers discover potential new target for treatments
Monday, November 21, 2011 - 07:00
in Health & Medicine
(PhysOrg.com) -- Colorado State University researchers have discovered an enzyme that is critical to the survival and replication of the bacterial pathogen that causes tuberculosis. The enzyme may become a key target for new drugs that could halt the manifestation of tuberculosis and potentially cut the current treatment strategy of multiple antibiotics given daily for at least six months.